CareDx, Inc (CDNA) vs Enliven Therapeutics, Inc. (ELVN)

A side-by-side comparison of CareDx, Inc and Enliven Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDNA vs ELVN

growth of $100 · dividends reinvested · last 7y
CDNA +206.4% (+17.3%/yr)ELVN -24.2% (-3.9%/yr)CDNA compounded faster over this window
0100200300400Start $100202120222023202420252026$306$76
CDNA ELVN

CDNA vs ELVN: by the numbers

  • •CDNA is the larger company ($3.30B vs $3.03B market cap).
  • •CDNA is profitable (24.23% net margin) while ELVN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCDNAELVN
P/E ratio30.80N/A
Forward P/E53.26N/A
P/S ratio7.20N/A
P/B ratio7.753.38
EV / EBITDA189.34N/A
FCF yield2.58%N/A

Profitability

MetricCDNAELVN
Gross margin70.58%0.00%
Operating margin-0.92%0.00%
Net margin24.23%0.00%
ROE26.08%-11.83%
ROIC-0.93%-13.88%

Growth (annualized)

MetricCDNAELVN
Revenue CAGR (5Y)12.56%N/A
Total return CAGR (5Y)1.33%24.57%

Frequently asked

Is CDNA or ELVN more profitable?
CDNA runs the higher net margin — CDNA at 24.23% versus ELVN at 0.00%.
How have CDNA and ELVN total returns compared?
Over the past 5 years, CDNA delivered 1.33% and ELVN delivered 24.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.